(00:32)
 Can you please tell our listeners a little about yourself and your background?

(01:00)
 Mayo Clinic Laboratories already offers one test for Alzheimer's disease, right?

(01:32) 
 Could you tell our listeners about the new FDA-approved test that Mayo Clinic Laboratories will launch soon?

(02:43)
 The test results will report the ratio of the amyloid isoforms, not the individual test components, right?

(03:26)
 Does the new test require a certain tube?

(04:15)
 Can you provide a little more detail on the commercially available tube that will be required?

(04:36)
 Which patient population would benefit most from this test?

(05:30)
 Can you compare and contrast the existing Alzheimer's disease test and the new amyloid ratio evaluation?

(08:58)
 Is Mayo Clinic's ADEVL the only test that measures the tau component?

(09:51)
 When would one of these tests be more appropriate than the other?

(10:52)
 Can you help our listeners understand what a "laboratory developed" test means?

(11:43)
 From a physician's standpoint, how might this new test improve patient care?